PTC Therapeutics

Biotech & Life Sciences · South Plainfield, United States · Founded 1998 · IPO 2013

A science-led, patient-centered biopharmaceutical company focused on discovering, developing and commercializing medicine for patients with rare disease

Valuation $4.14B

Revenue $1.24B

EBITDA $412M

Power Law Unicorn$1–10B valuation tier Thoroughbred$100M+ revenue

Knowledge graph

News PTC Therapeutics prices $500M convertible notes, repurchases 2026 notes Jun 16, 2026

Talent graph

PTC Therapeutics's talent

Book a demo to see the people

Employees mapped 1,150 incl. 3 AI specialists

Founders /100 quality score

Key operators 10 quality /100

Potential founders likely future founders

Startup mafia 8 alumni-founded startups

Talent movements in · out past 12 months

Source: Dealroom Talent Intelligence.

Investors

21 investors on PTC Therapeutics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 21 investors entered at this stage

HealthCap

Longwood Fund

HBM BioVentures

Jennison Associates

HBM Healthcare Investments

Novo Holdings

CDIB Capital Group

Rutgers university

Adage Capital

Credit Suisse First Boston

Delphi Ventures

Cercano Management

Manulife Financial

Bay City Capital

Celgene

Credit Suisse

New Medical Technologies

The Column Group

Amgen Ventures

Brookside Capital

CDI Bioscience

PTC Therapeutics mafia

Startups founded by PTC Therapeutics alumni

Former PTC Therapeutics employees who went on to start their own companies. Sorted by Dealroom signal score.

Kailera TherapeuticsEst. 2024

Ron RenaudUnited States

Signal score95

Signify BioEst. 2024

RIRa Session IiUnited States

Signal score88

DispelEst. 2014

ESEthan SchmertzlerUnited States

Signal score85

PikralidaEst. 2019

Stanisław PikulPoland

Signal score72

Nionyx BioEst. 2025

MTMagdalena TyrpienUnited States

Signal score71

FibronosticsEst. 2015

Roni AmielUnited States

Signal score67

InozymeEst. 2016

Axel BolteUnited States

Signal score62

ZoomiEst. 2012

WJWilliam JuUnited States

Signal score51

Book a demo to explore the full alumni network →

Global footprint

Where PTC Therapeutics has talent and traffic

Workforce by country

31 countries with
team presence

🇺🇸 United States69.9%

🇧🇷 Brazil7.6%

🇮🇪 Ireland4.9%

🇨🇭 Switzerland2.6%

🇬🇧 United Kingdom1.7%

Top 5 of 31 shown

Web traffic by country

54K monthly visits
across markets

🇺🇸 United States59.3%

🇬🇧 United Kingdom20.6%

🇨🇦 Canada5%

🇮🇳 India3.7%

🇫🇷 France2.2%

Top 5 markets shown

Patent intelligence

$168M patent portfolio · 118 active families

Estimated portfolio value

$168M

4.0% of market cap · 127.5× larger than top peer Vividion Therapeutics ($1M)

118 active patent families

Where PTC Therapeutics innovates BiochemistryDiseaseHuntingtons choreaMedicinal chemistryMedicine

Where PTC Therapeutics concentrates vs peers

Each axis is a top-10 topic across PTC Therapeutics and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about PTC Therapeutics

An AI-synthesized read of the highest-engagement posts about PTC Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See PTC Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles